HDL Cholesterol Kits Market Size (2024 - 2029)

The HDL cholesterol kits market is anticipated to experience growth over the forecast period, driven by the increasing need for cholesterol screening, particularly in populations at risk due to obesity, hyperlipidemia, and diabetes. The COVID-19 pandemic initially hindered market expansion by reducing hospital visits and cholesterol testing procedures. However, as services resume and awareness programs expand, the demand for cholesterol testing is expected to rise, contributing to market growth. Despite challenges such as testing inaccuracies, the overall market size is projected to expand as public health initiatives and lifestyle changes emphasize the importance of early cholesterol detection to prevent chronic diseases.

Market Size of HDL Cholesterol Kits Industry

HDL Cholesterol Kits Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 6.20 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

HDL Cholesterol Kits Market Major Players

*Disclaimer: Major Players sorted in no particular order

HDL Cholesterol Kits Market Analysis

The HDL cholesterol kits market is poised to grow at a CAGR of 6.2% over the forecast period.

The emergence of the COVID-19 pandemic has had an adverse effect on the world economy and the healthcare system. People with underlying risk conditions and obesity were at greater risk during the COVID-19 pandemic. For instance, as per the data published by the CDC in March 2021, around 30.2% of the total COVID-19 hospitalizations were attributed to obesity. It was observed that obesity had increased exponentially during the pandemic. For instance, an article published in Diabetes, Obesity and Metabolism in August 2021 showed that obesity prevalence is a significant and potentially modifiable risk factor for increased COVID-19 national caseload and mortality. The COVID-19 pandemic restricted patient visits in hospitals and clinics, which decreased the number of cholesterol testing procedures and hence impacted market growth. However, with the release of restrictions and resumed services, the market is expected to increase over the forecast period.

The growing importance of cholesterol screening in obese, hyperlipidemic, and diabetic populations, as well as growing awareness programs for high-risk cholesterol, are expected to drive market growth.

The incidence of obesity has been increasing fiercely over the past decades, and it is often described as a global endemic, especially in developed and developing countries where lifestyle-related disorders, such as anxiety, stress, smoking, and drinking, are more prevalent. Also, obesity is a key risk factor for type 2 diabetes, cardiovascular disease, and hypertension, and it has also been linked to brain illnesses like Alzheimer's disease. For instance, according to the 2021 data published by the WHO, an estimated 38.2 million children under the age of 5 were overweight or obese in 2021. The increasing consumption of junk and processed foods by children decreases the number of vitamins in the body, which is expected to increase the risk of developing high cholesterol. This raises the need to routinely screen cholesterol levels, which is anticipated to propel market growth over the forecast period.

Similarly, according to World Obesity Atlas data from 2022, 27 million children in India are expected to be obese by 2030. Thus, obesity increases the risk of developing high cholesterol due to an unhealthy diet, a lack of exercise, and underlying conditions such as diabetes. This is expected to increase the demand for cholesterol testing in order to reduce the risk of developing cardiovascular disease, fueling the growth of HDL cholesterol test kits over the forecast period.

Furthermore, according to a February 2021 article, dyslipidemia is a major risk factor for cardiovascular disease. Furthermore, an unacceptably high incidence of dyslipidemia has been discovered in Mekelle City's adult population, emphasizing the critical need for early detection and public health interventions through the coordinated involvement of governmental, non-governmental, and public groups. This is expected to increase the population's need for early detection of cholesterol in order to avoid the risks of developing various chronic diseases. Therefore, all the aforementioned factors are expected to fuel market growth.

However, the errors and inaccuracies in HDL cholesterol testing methods are likely to impede the market's growth over the forecast period.

HDL Cholesterol Kits Industry Segmentation

As per the scope of the report, HDL cholesterol kits are fluorometric assays that can measure the amounts of HDL cholesterol present in plasma or serum samples within a 96-well microtiter plate format. The HDL Cholesterol Kits Market is segmented by Product Type (HDL and LDL/VLDL Assay Kit and HDL Cholesterol Direct Reagent Kit), by End User (Hospitals, Diagnostic Laboratories, and Other End Users), and by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type
HDL and LDL/VLDL Assay Kit
HDL Cholesterol Direct Reagent Kit
By End User
Hospitals
Diagnostic Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

HDL Cholesterol Kits Market Size Summary

The HDL cholesterol kits market is anticipated to experience significant growth over the forecast period, driven by the increasing prevalence of obesity, hyperlipidemia, and related health conditions. The COVID-19 pandemic initially hindered market expansion by reducing hospital visits and cholesterol testing procedures. However, as restrictions have eased and healthcare services have resumed, the market is expected to recover and grow. The rising awareness of cholesterol screening, particularly among obese, diabetic, and hyperlipidemic populations, is a key factor propelling market growth. The demand for cholesterol testing kits is further fueled by the growing incidence of lifestyle-related disorders and the need for early detection of dyslipidemia to prevent chronic diseases such as cardiovascular conditions.

North America is projected to dominate the HDL cholesterol kits market due to high obesity rates, advanced healthcare infrastructure, and substantial healthcare expenditure. The region's focus on technological advancements in cholesterol detection and testing devices is expected to drive market growth. The market is moderately competitive, with major players like Abbott, Randox Laboratories Ltd, and Thermo Fisher Scientific expanding their presence globally through strategic initiatives. The introduction of innovative products, such as liquid-stable HDL cholesterol verifier kits, highlights the ongoing efforts to meet the increasing demand for accurate and efficient cholesterol testing solutions. These factors collectively contribute to the anticipated growth of the HDL cholesterol kits market over the forecast period.

Explore More

HDL Cholesterol Kits Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Importance of Cholesterol Screening in the Obese, Hyperlipidemic, and Diabetic Population

      2. 1.2.2 Growing Awareness Programs for High-Risk Cholesterol

    3. 1.3 Market Restraints

      1. 1.3.1 Errors and Inaccuracy in HDL Cholesterol Testing Methods

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product Type

      1. 2.1.1 HDL and LDL/VLDL Assay Kit

      2. 2.1.2 HDL Cholesterol Direct Reagent Kit

    2. 2.2 By End User

      1. 2.2.1 Hospitals

      2. 2.2.2 Diagnostic Laboratories

      3. 2.2.3 Other End Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

HDL Cholesterol Kits Market Size FAQs

The HDL Cholesterol Kits Market is projected to register a CAGR of 6.20% during the forecast period (2024-2029)

Abbott Laboratories, Randox Laboratories Ltd., Thermo Fisher Scientific, Abcam plc and Merck KGaA are the major companies operating in the HDL Cholesterol Kits Market.

HDL Cholesterol Kits Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)